Saturday, 21 November 2026
M
Meridian Globe
Live briefing

A multicenter, dose-ranging human challenge study of a recombinant influenza A (A/Texas/71/2017 (H3N2)) virus in healthy adult volunteers

Source Nature 医学研究1d ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Health
Region
Global
Language
English
Item ID
health-be113763

Comments 0 comments

No comments yet. Be the first.

A multicenter, dose-ranging human challenge study of a recombinant influenza A (A/Texas/71/2017 (H3N2)) virus in healthy adult volunteers · Meridian Globe